You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

AHSCT

Showing 26 - 50 of 77
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

High-risk Diffuse Large B-cell Lymphoma Trial in Worldwide (Blinatumomab)

Terminated
Has Results
  • High-risk Diffuse Large B-cell Lymphoma
  • Atlanta, Georgia
  • +31 more
Sep 10, 2020

GVHD Trial in United States (RGI-2001, Calcineurin Inhibitors, Allogeneic Hematopoietic Stem Cell Transplantation)

Completed
  • Graft Versus Host Disease
  • San Diego, California
  • +5 more
Oct 15, 2019

Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Myelodysplastic Syndrome Trial in Duarte (procedure, biological, drug,

Recruiting
  • Acute Lymphoblastic Leukemia
  • +3 more
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • +8 more
  • Duarte, California
    City of Hope Medical Center
Jan 12, 2023

Primary CNS Lymphoma Trial in Hanzhou (Orelabrutinib, Rituximab, Methotrexate)

Recruiting
  • Primary Central Nervous System Lymphoma
  • Hanzhou, Zhejiang, China
    2nd Affiliated Hospital, School of Medicine, Zhejiang University
Nov 3, 2022

Multiple Sclerosis Trial in Saint Petersburg (Rituximab)

Recruiting
  • Multiple Sclerosis
  • Saint Petersburg, Russian Federation
    First Pavlov State Medical University of St. Petersburg
Oct 1, 2021

Lymphoma Trial in Cairo (BEAM Protocol, CEM protocol)

Recruiting
  • Lymphoma
  • BEAM Protocol
  • CEM protocol
  • Cairo, Egypt
    International Medical Center (IMC) Hospital, Cairo, Egypt.
Apr 1, 2023

Invasive Fungal Infections in Patients Following Stem Cell

Unknown status
  • Invasive Fungal Infections
  • Stem Cell Transplant Complications
  • No intervention
  • Melbourne, Victoria, Australia
    Peter MacCallum Cancer Centre
Nov 4, 2020

Diffuse Large B-cell-lymphoma Trial in Saint Louis, Cleveland (Venetoclax, Rituximab, Ifosfamide)

Active, not recruiting
  • Diffuse Large B-cell-lymphoma
  • Saint Louis, Missouri
  • +2 more
Nov 14, 2022

Multiple Myeloma, Complication Trial in Lyon (Interpretation of the results from the detection visit, Explaining detection

Not yet recruiting
  • Multiple Myeloma
  • Complication
  • Interpretation of the results from the detection visit
  • +3 more
  • Lyon, France
    Centre Léon Bérard
Jul 7, 2023

Severe Aplastic Anemia, MDS (Myelodysplastic Syndrome) Trial in Baltimore, Bethesda, Minneapolis (Miltenyi CD34 Reagent System,

Recruiting
  • Severe Aplastic Anemia
  • MDS (Myelodysplastic Syndrome)
  • Miltenyi CD34 Reagent System
  • Donor derived G-CSF mobilized PBC
  • Baltimore, Maryland
  • +2 more
Jan 25, 2023

Non-Hodgkin's Lymphoma, Hodgkin's Lymphoma, Multiple Myeloma Trial in Boston (GCSF, meloxicam, Placebo)

Completed
Has Results
  • Non-Hodgkin's Lymphoma
  • +3 more
  • Boston, Massachusetts
    Massachusetts General Hospital
May 15, 2020

Malignant Hematologic Tumor Trial in London (Parenteral Nutrition/Enteral Nutrition)

Unknown status
  • Malignant Hematologic Neoplasm
  • Parenteral Nutrition/Enteral Nutrition
  • London, Ontario, Canada
    London Health Sciences Centre-Victoria Hospital
Mar 27, 2020

Haematological Malignancy, Acute Leukemia, MDS Trial in Lyon (Physical activity program)

Not yet recruiting
  • Haematological Malignancy
  • +5 more
  • Physical activity program
  • Lyon, France
    Institut d'Hématologie et d'Oncologie Pédiatrique
Mar 25, 2022

Acute Lymphoblastic Leukemia, Adult B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1 Trial in United States

Completed
Has Results
  • Acute Lymphoblastic Leukemia
  • Adult B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1
  • Alemtuzumab
  • +20 more
  • Palo Alto, California
  • +100 more
Aug 3, 2022

Extranodal NK-T-Cell Lymphoma, Nasal and Nasal-Type Trial in Guangzhou (pegaspargase, Gemcitabine, Oxaliplatin)

Recruiting
  • Extranodal NK-T-Cell Lymphoma, Nasal and Nasal-Type
  • Guangzhou, Guangdong, China
    Department of Medical Oncology, Sun Yat-sen University Cancer Ce
Mar 12, 2021

Treatment Refusal Trial in Guangzhou (Gemcitabine, etoposide, Pegaspargase)

Unknown status
  • Treatment Refusal
  • Guangzhou, Please Select, China
    Sun Yat-sen University Cancer Center
Dec 16, 2020

Lymphoma, Non-Hodgkin's, Adult, Lymphoma, Hodgkin's, Adult Trial (FE 203799)

Withdrawn
  • Lymphoma, Non-Hodgkin's, Adult
  • Lymphoma, Hodgkin's, Adult
  • FE 203799
  • (no location specified)
Oct 22, 2020

Cancer Trial in Los Angeles (itraconazole, voriconazole)

Completed
  • Cancer
  • Los Angeles, California
    Jonsson Comprehensive Cancer Center, UCLA
Jul 30, 2020

Stem Cell Transplant Complications Trial (MHC typing, KIR typing, Assessment of KIR-based prediction scores)

Completed
  • Stem Cell Transplant Complications
  • MHC typing
  • +2 more
  • (no location specified)
May 9, 2021

Neuromyelitis Optica Trial in Calgary (AHSCT)

Terminated
  • Neuromyelitis Optica
  • AHSCT
  • Calgary, Alberta, Canada
    Foothills Medical Centre, University of Calgary
Apr 30, 2018

Haematological Malignancy, Acute Leukemia, MDS Trial in Lyon (Physical activity program)

Withdrawn
  • Haematological Malignancy
  • +5 more
  • Physical activity program
  • Lyon, France
    Institut d'Hématologie et d'Oncologie Pédiatrique
Feb 10, 2022

Recurrent DLBCL Activated B-Cell Type, Refractory DLBCL Activated B-Cell Type Trial in Saudi Arabia, United States (procedure,

Recruiting
  • Recurrent Diffuse Large B-Cell Lymphoma Activated B-Cell Type
  • Refractory Diffuse Large B-Cell Lymphoma Activated B-Cell Type
  • Autologous Bone Marrow Transplantation
  • +10 more
  • Anchorage, Alaska
  • +282 more
Aug 19, 2022

Hematological Malignancies, Myelodysplastic Syndrome, Leukemia Trial in Houston (Mycophenolate Mofetil (MMF), Thymoglobulin,

Terminated
Has Results
  • Hematological Malignancies
  • +3 more
  • Mycophenolate Mofetil (MMF)
  • +3 more
  • Houston, Texas
    UT MD Anderson Cancer Center
Sep 1, 2020

Leukemia Trial in Houston (drug, radiation, biological)

Active, not recruiting
  • Leukemia
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
May 22, 2019

Lymphoma Trial in Omaha (biological, drug, procedure)

Completed
  • Lymphoma
  • rituximab
  • +6 more
  • Omaha, Nebraska
    UNMC Eppley Cancer Center at the University of Nebraska Medical
Jan 22, 2018